Jones Day advised Bpifrance (SPI fund) in the deal. CorWave announced it has secured €61m ($66m) at the close of its second round of Series C funding....
CorWave’s €61 Million Series C Funding Round
Expliseat’s €17 Million Series B Financing
Jones Day advised Bpifrance (SPI fund), GoCapital and NCI on the deal. Expliseat has successfully closed a Series B financing round, raising €17 million in funding....
Amolyt Pharma’s Research Agreement and Licensing Option with XOMA
Jones Day advised Amolyt Pharma on the deal. Amolyt Pharma (“Amolyt,” “Amolyt Pharma” or the “Company”), a global company specialized in developing innovative therapies for rare...
Amolyt Pharma’s EUR 138 Million Fund Raising
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
Masteos’ €40 Million Series A Financing Round
Paris-based Masteos, a rental investment one-stop-shop, has raised €40 million in a Series A investment round, just 9 months since bringing home €15 million in a seed round...
Domain Therapeutics’ €39 Million Fundraising
Chammas & Marcheteau advised Turenne Capital on the deal. Lavery de Billy and Bird & Bird represented Domain Therapeutics. Jones Day advised CTI Life Sciences Fund,...
Domain Therapeutics’ €38 Million Fundraising
Chammas & Marcheteau advised Turenne Capital on the deal while Bird & Bird represented Domain Therapeutics. Jones Day advised CTI Life Sciences Fund, Panacea Venture, and...
Fortino Capital’s Majority Stake Acquisition in Bonitasoft
Jones Day advised Fortino Capital Partners NV on the deal. Fortino Capital Partners NV acquired a majority stake in Bonitasoft, a leading software company active in...
Finspot’s €30 Million Series B Financing Round
Jones Day advised Finspot on the deal. Pretto (Finspot), a French-based company engaged in online mortgage brokerage, announced its €30 million Series B round of financing led...
Amolyt Pharma’s $80 Million Series B Financing Round
Goodwin Procter advised Sectoral Asset Management and Andera Partners on the deal. McDermott Will & Emery advised a syndicate of Amolyt Pharma’s historical investors, including LSP,...